Patient Support Hotline

Call (844) 244-1309

ZERO360 is a free, comprehensive patient support service to help patients and their families navigate insurance and financial obstacles to cover treatment and other critical needs associated with cancer.


Subscribe to our E-Newsletter

Stay up-to-date on the latest news about prostate cancer. Join our distribution list to receive periodic email updates and our monthly e-newsletter.

  • Patient Support (844) 244-1309
  • Search
  • e-News Signup Enews Signup
  • Run/Walk
  • Donate

Cal Ripken, Jr. Goes to Bat as Mission Speaker for 2021 Virtual ZERO Prostate Cancer Summit


Ilana Ostrin

Cal Ripken, Jr. Goes to Bat as Mission Speaker for 2021 Virtual ZERO Prostate Cancer Summit

Baseball All-Star will share his personal prostate cancer story with patients and families nationwide

December 8, 2020 — Washington, D.C. — Baseball Hall of Fame Legend and 19-time All-Star Cal Ripken, Jr. (known as “The Iron Man”) will head to bat as the official mission speaker of the 2021 ZERO Prostate Cancer Summit. The ZERO Prostate Cancer Summit, hosted by ZERO – The End of Prostate Cancer and held virtually this winter, brings together the top minds in medicine, research,  education, and advocacy with a national community of passionate prostate cancer patients, survivors, caregivers, and loved ones. On March 1, Ripken will be joined alongside his physician and urologist, Dr. Ronald Tutrone of Chesapeake Urology Associates, to share his personal prostate cancer story of faith and triumph.

The former Baltimore Orioles “Iron Man” is one of baseball’s all-time greatest athletes, known for playing in 2,632 consecutive games, eclipsing what was once thought to be an unbreakable record of 2,130 previously set by the legendary Lou Gehrig.

In August, the 21-year Major Leaguer announced that he was recently diagnosed with and successfully treated for prostate cancer. “When I learned I had prostate cancer, I was shocked, since I didn’t present any traditional signs or symptoms of the disease,” said Ripken. “Now I know this is a common experience for many men who battle this ‘silent killer’ and I’m proud and honored to share my story at the ZERO Summit.”

“Cal Ripken has provided a lifetime of inspiration to many. His story will empower and inspire Summit attendees and all those impacted by this awful disease to give them hope and courage,” said Jamie Bearse, ZERO CEO. “We are beyond grateful for the awareness he’s bringing to this extremely common disease that kills a man every 18 minutes.”

Ripken will deliver his remarks live on Monday, March 1, 2021 (the specific time of his broadcast is to be announced at a later date). His broadcast can be viewed live on Facebook and the web at facebook.com/zerocancer or zerocancer.org/summit. Viewers are encouraged to register for the Summit to receive event updates and information on additional speakers and topics. It’s free to sign up at zerocancer.org/summit.

Since its inception more than 25 years ago, the Annual ZERO Summit has become the most impactful meeting in the prostate cancer community. More than 1,000 attendees are expected to attend the upcoming virtual ZERO Summit. This year’s Summit moved to an online format due to COVID-19, but will still bring the prostate cancer community together to share the latest breaking news and information related to disease education, research breakthroughs, advocacy efforts, and more.

ZERO is grateful to our partner and Summit sponsor, Exosome Diagnostics, for helping bring Cal Ripken, Jr. to the Summit audience. Ripken learned of his prostate cancer diagnosis via the ExoDx Prostate test, a non-invasive urine test that helps a man and his physician determine the risk of high-grade prostate cancer on biopsy. Members of the media wishing to speak with Ripken regarding his prostate cancer experience can email Karla.Gonye@bio-techne.com.


About Exosome Diagnostics

Exosome Diagnostics, a Bio-Techne brand, is a world leader in developing liquid biopsy-based diagnostics. The company has clinical laboratories in Waltham, MA (US) and Munich (DE) to support its diagnostics and biopharma segments. Exosome Diagnostics’ non-invasive, exosome-based urine test known as the ExoDx™ Prostate test, or EPI, is a commercially available risk assessment tool for detection of high-grade prostate cancer in men considering prostate biopsy. It is currently available as a laboratory developed test (LDT) through urologists and will soon be offered as CE-IVD in Europe. The test achieved FDA Breakthrough Device designation, is included in the National Comprehensive Cancer Network (NCCN) May 2019 guidelines, received a 10-year unlimited General Services Administration Award, and received a positive Medicare coverage decision.

About Cal Ripken, Jr.

Cal Ripken, Jr. is a member of the National Baseball Hall of Fame and played his entire 21-year Major League career with his hometown Baltimore Orioles. He was a 19-time American League All-Star, a two-time American League Most Valuable Player and two-time All-Star Game MVP. He is one of ten players in history with more than 3,000 hits and 400 home runs. Since retirement Ripken has built a youth baseball business and a national non-profit organization. Ripken Baseball runs tournament destination sites called “The Ripken Experience” in his hometown of Aberdeen, MD, Myrtle Beach, SC, Pigeon Forge, TN and at Disney’s Wide World of Sports complex in Orlando, FL. In 2001 he and his family started the Cal Ripken, Sr. Foundation in honor of the family’s patriarch. Today the foundation serves underserved youth across the country through programs such as Badges for Baseball and the construction of Youth Development Parks that provide kids with safe places to play and learn. In 2020 the foundation will impact over 1 Million kids nationwide and will built its 100th Youth Development Park. In addition, Ripken is a best-selling author, an accomplished corporate speaker and a popular corporate spokesperson. Ripken is also a Public Diplomacy Envoy for the U.S. State Department and since 2007 he has made goodwill trips to China, Japan, Nicaragua and the Czech Republic.

About ZERO — The End of Prostate Cancer
ZERO — The End of Prostate Cancer is the leading national nonprofit with the mission to end prostate cancer and help all who are impacted. ZERO advances research, provides support, and creates solutions to achieve health equity to meet the most critical needs of our community. From early detection to survivorship, ZERO is the premier resource for prostate cancer patients and their families to access comprehensive support, make meaningful connections, and take action to save lives. Our dedicated national and chapter staff is joined with a growing team of passionate volunteer champions to increase advocacy, awareness, and community engagement to ZERO out prostate cancer. ZERO is recognized with four out of four stars by Charity Navigator and accredited by the Better Business Bureau. ZERO spends more on programs than any other prostate cancer charity, dedicating 85 cents of every dollar to support, education, and research.